This is a community-generated profile. If you would like to claim it, please .
Lysosomal Therapeutics Funding
$0
22 rounds
Lysosomal Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on February 4, 2015.
Funding Rounds
A
$20000000U
$4800000Investors of Lysosomal Therapeutics
Partners Innovation Fund
Rounds
A
U
Hatteras Venture Partners
Rounds
A
U
Lilly Ventures
Rounds
A
U
Roche Venture Fund
Rounds
A
U
Atlas Venture
Rounds
A
U